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Membrane proteinA number of missense mutations in subunit I of cytochrome c oxidase (CytcO) have previously been linked to
prostate cancer (Petros et al., 2005). To investigate the effects of these mutations at the molecular level, in the
present study we prepared four different structural variants of the bacterial Rhodobacter sphaeroides CytcO
(cytochrome aa3), each carrying one amino-acid residue replacement corresponding to the following
substitutions identiﬁed in the above-mentioned study: Asn11Ser, Ala122Thr, Ala341Ser and Val380Ile
(residues Asn25, Ser168, Ala384 and Val423 in the R. sphaeroides oxidase). This bacterial CytcO displays
essentially the same structural and functional characteristics as those of the mitochondrial counterpart. We
investigated the overall activity, proton pumping and internal electron- and proton-transfer reactions in the
structural variants. The results show that the turnover activities of the mutant CytcOs were reduced by at
most a factor of two. All variants pumped protons, but in Ser168Thr, Ala384Ser and Val423Ile we observed
slight internal proton leaks. In all structural variants the internal electron equilibrium was slightly shifted
away from the catalytic site at high pH (10), resulting in a slower observed ferryl to oxidized transition.
Even though the effects of the mutations were relatively modest, the results suggest that they destabilize
the proton-gating machinery. Such effects could be manifested in the presence of a transmembrane
electrochemical gradient resulting in less efﬁcient energy conservation. This article is part of a Special Issue
entitled: Allosteric cooperativity in respiratory proteins., negative and positive sides of
, (rate constant)−1
ric cooperativity in respiratory
6 8 153679.
ll rights reserved.© 2011 Elsevier B.V. All rights reserved.1. Introduction
The human mitochondrial DNA (mtDNA) encodes 37 genes of
which 13 are polypeptides of the respiratory chain complexes. For
over 20 years it has been known that mutations in the mtDNA are
found in connection to diseases such as themitochondrial myopathies
MELAS, LHON and MERFF (reviewed in [1]). More recently, mutations
of the mtDNA have been found in connection to neurodegenerative
diseases [2–5], ageing (reviewed in [6]) as well as different types
of cancers [7–11]. Often, mtDNA mutations affect the function of
one or several complexes of the respiratory chain. However, the
link (if any) between tumorigenesis and effects of mtDNA mutations
at a molecular/functional level is largely unknown. Most mtDNA
mutations related to various cancers or tumors have been identiﬁed
in genes encoding subunits of complex I, but there are also a great
number of reports of mutations in genes encoding the other
respiratory complexes, including CytcO (reviewed in [12]). In 2005,
Petros et al. sequenced the mtDNA from tumor cells of a numberof prostate cancer patients and found that the number of missense
mutations in subunit I of CytcO was signiﬁcantly increased compared
to controls [13]. In total, 21mutations in CytcOsubunit Iwere reported.
However, the effects of these mutations on the activity of CytcO at the
molecular level were not investigated.
In the present study, four of the missense mutations found in
subunit I of CytcO in prostate cancer cells [13]; Asn11Ser, Ala122Thr,
Ala341Ser and Val380Ile were introduced into the CytcO of the purple
bacterium Rhodobacter sphaeroides, which is used as a well-studied
model of the mitochondrial counterpart [14–17]. The functional
effects of these mutations were investigated in detail by measuring
the overall activities, proton pumping and rates of speciﬁc electron-
and proton-transfer reactions.
The R. sphaeroides CytcO is composed of four subunits where
subunits I–III, the catalytic core, nearly identical (sequence and
structure) to those of the mammalian CytcO [14,18–20] (in R.
sphaeroides SU IV is composed of only one transmembrane helix).
In previous studies, CytcOs from yeast, R. sphaeroides and P.
denitriﬁcans have been used to investigate the effect of other
disease-related mutations on the function of CytcO [16,17,21–25].
Similar to the mitochondrial CytcO, in the R. sphaeroides CytcO
electrons are initially transferred from cytochrome c to CuA located
in SU II. From there, electrons are transferred consecutively to
heme a and to the catalytic site, composed of heme a3 and CuB,
where O2 binds and is reduced to water. The O2 reduction reaction
is linked to proton pumping from the more negative (N) side of
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approximately one pumped proton per electron transferred to the
catalytic site.
In the R. sphaeroides CytcO the protons needed for O2 reduction
and those that are pumped are taken up from the N side of the
membrane through two proton pathways. One of these pathways is
called the K-pathway as it holds a highly conserved Lys residue
(Lys362). The other pathway is called the D-pathway. It is deﬁned by
an Asp residue (Asp132) near the protein surface on the N side, which
is connected by ~10 water molecules to the highly conserved Glu286
residue located between the two heme groups at a distance of ~10 Å
from the catalytic site. From Glu286 protons are transferred either
toward the catalytic site (substrate protons used in O2 reduction) or
toward the heme propionates, which are found on the trajectory of
the pumped protons.
The four mutations, Asn11Ser, Ala122Thr, Ala341Ser and Val380Ile,
found in CytcO in human prostate cancer cells were chosen because
these residues are highly conserved among species (in theR. sphaeroides
enzyme they correspond to Asn25, Ser168, Ala384 and Val423). As
seen in Fig. 1, the locations of the mutated amino-acid residues are
almost identical in the R. sphaeroides and the mitochondrial CytcO
structures.
2. Materials and methods
2.1. Site-directed mutagenesis, cell growth and CytcO puriﬁcation
The mutations were constructed using the Quick-Change site-
directed mutagenesis kit (Stratagene). They were introduced into
subunit I of CytcO encoded on the pJS3-SH plasmid [26]. The mutated
fragment was transferred to the expression plasmid pRK415-1 [27]
containing the genes for subunits I–III of R. sphaeroides CytcO,
with a 6His-tag attached to SU I and also containing a gene for
tetracycline resistance. Themutated pRK415-1 plasmidwas transferred
into cells of the Escherichia coli S-17 strain by electroporation and
then into the R. sphaeroides JS100 strain by conjugation. The mutations
were veriﬁed by sequencing. To express the CytcO, R. sphaeroides cells
were grown aerobically in the dark in a SIS minimal medium and in the
presence of tetracycline. CytcOwas solubilized from the cell membraneFig. 1. Structural alignment of subunit I of cytochrome c oxidase from Rhodobacter sphaeroid
the four mutated amino acids are shown in blue (R. sphaeroides) and grey (bovine heart).fraction using dodecyl-β-D-maltoside (DDM) and the His-tagged CytcO
was puriﬁed using Ni2+-NTA afﬁnity chromatography, as described
previously [28].
2.2. Steady-state kinetics
The steady-state enzyme kinetics wasmeasured using a Clark-type
O2 electrode (Hansatech instruments). In this assay, 50 mM K+-
phosphate buffer at pH 6.5, supplementedwith 0.05% DDMwas added
to the sample chamber to a ﬁnal volume of 1 ml. Then, 36 μM reduced
cytochrome c was added. The reaction was initiated by addition of
0.1 nM puriﬁed CytcO and the O2 consumption was monitored. The
CytcO activity, deﬁned as the number of electrons transferred from
reduced cytochrome c to CytcO per second per enzyme complex, was
calculated.
2.3. Proton-pumping measurements
Liposomes containing CytcOwere prepared as described [29]. Each
proteoliposome typically contained at most one enzymemolecule and
in 75% of the vesicles the CytcO molecules were oriented with the
cytochrome c-binding site toward the outside solution [30]. To
measure the proton-pumping stoichiometry, liposome-reconstituted
CytcOat a concentration of 0.5 μM in the presence of 5 μMvalinomycin
was mixed at a 1:1 ratio with 16 μM reduced cytochrome c using a
stopped-ﬂow spectrophotometer (Applied Photophysics). The CytcO
as well as the cytochrome c were diluted in a solution containing
50 μMHepes-KOH, 45 mMKCl, 4 mMsucrose, 1 mMEDTAand0.1 mM
of the pH-sensitive dye phenol red at pH 7.3–7.6. Absorbance changes
of phenol red were detected at 554 nm. Then, 5 μM of the proton
ionophore carbonyl cyanide 3-chlorophenylhydrazone (CCCP) was
added to the proteoliposome sample and the measurement was
repeated with the uncoupled system, detecting the net consumption
of protons during enzyme turnover.
2.4. Oxygen reduction kinetics
CytcO at a concentration of ~7 μM in 100 mM KCl, 200 μM Hepes-
KOH at pH 7.4, 0.1% DDM was reduced with 2 mM ascorbate andes (green) (PDB entry 1M56) and bovine heart (red) (PDB entry 1OCC). The location of
time(s)



















Fig. 3. Absorbance changes of the pH dye phenol red associated with proton uptake and
release by CytcO. Liposome-reconstituted CytcO was mixed at a 1:1 ratio with 16 μM
reduced cytochrome c in a stopped-ﬂow spectrophotometer. Absorbance changes
of phenol red were detected at 554 nm. A decrease in absorbance is associated
with release of (pumped) protons to the outside of the vesicles. After addition of
5 μM of the proton ionophore CCCP the net consumption of protons was measured
(increase in absorbance). Experimental conditions after mixing: 0.25 μM CytcO, 2.5 μM
valinomycin, 8 μM reduced cytochrome c, 50 μM Hepes-KOH, 45 mM KCl, 44 mM
sucrose, 1 mM EDTA and 100 μM phenol red at pH 7.3–7.6.
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complete reduction of CytcO, veriﬁed by analysis of the absorption
spectrum, the N2 atmosphere was exchanged for CO, which binds
to reduced heme a3. The reduced CytcO–CO complex was mixed at
a ratio of 1:5 with an O2-saturated buffer solution in a stopped-
ﬂow apparatus (Applied Photophysics). Approximately 200 ms
after mixing, the CO molecule was dissociated by means of a short
laser ﬂash (Quantel Brilliant B, ~200 mJ, 532 nm) enabling O2 to
bind to the reduced catalytic site, and the reaction to proceed.
Absorbance changes at single wavelengths were recorded as a
function of time. The rate constants and amplitudes of the transient
absorbance changes during the reaction were analyzed by ﬁtting
the data to multi-exponential functions using the ProK software
(Applied Photophysics).
3. Results
The R. sphaeroides CytcOs containing the fourmutations; Asn25Ser,
Ser168Thr, Ala384Ser and Val423Ile (R. sphaeroides numbering) were
all expressed and puriﬁed. The spectral characteristics of the puriﬁed
mutated CytcOs did not differ from those of the wild-type enzyme
(not shown), which indicates that the metal cofactors, including
those constituting the catalytic site, were intact. The turnover
activities of the mutant CytcOs were measured as a function of pH
by measuring the O2-consumption rates and found to be at most a
factor of two lower than the corresponding activity of the wild-type
CytcO (Fig. 2).
3.1. Proton pumping
To measure the proton-pumping stoichiometry, the vesicle-
reconstituted CytcOwasmixed with an excess of reduced cytochrome
c in the presence of O2 and the pH indicator phenol red in a stopped-
ﬂow apparatus. The used cytochrome c:CytcO ratio allowed a total of
eight turnovers (i.e. 32 electrons from cytochrome c). Absorbance
changes of the pH-sensitive dye were monitored at 554 nm, which
is an isosbestic point for oxidation-reduction of cytochrome c. The
potassium ionophore valinomycin was added to prevent the buildup
of an electrical gradient that could inhibit the proton-pumping
activity. Fig. 3 shows the traces obtained from the proton-pumping
experiments with all four mutant CytcOs as well as the wild-type
CytcO. The protons being pumped out of the vesicles acidify thepH





























Fig. 2. The pH dependence of the steady-state turnover activity in electrons per second
of the wild-type CytcO and the four mutated variants. Each point is an average of two
measurements. Experimental conditions: 38 μM reduced cytochrome c, 0.1 nM
cytochrome c oxidase, 0.05% DDM, buffers as follows; 0.05 M K+-phosphate (pH 6.5
and 7.5), 0.05M Tris–HCl (pH 8.0), 0.05 M CHES (pH 9.0 and 9.5), 0.05 M CAPS (pH 10.0
and 10.5).outside solution, which results in a decrease in absorbance at 554 nm
of the pH-sensitive dye. Addition of the proton ionophore CCCP,
allows the pumped protons to equilibrate across the membrane
during turnover and only a net proton uptake, associated with the O2-
reduction, is seen as an increase in absorbance (alkalinization of the
medium). The data show that all four mutant CytcOs pumped protons,
although the stoichiometry was slightly lower with the Asn25Ser
mutant CytcO. Furthermore, the Ser168Thr, Ala384Ser and Val423Ile
mutant CytcOs displayed a slight increase in absorbance after the
initial decrease associated with proton-pumping. Such an increase is
indicative of a proton leak into the vesicles.
3.2. The O2 reduction reaction
The CytcO was fully reduced using ascorbate and PMS after which
the sample was incubated under CO atmosphere. The CO ligand binds
to the reduced heme a3 forming a heme a3–CO complex. The kinetics
of the reaction of the reduced CytcO with O2 was investigated by
mixing the four-electron reduced, CO-bound CytcO with O2 in a
stopped-ﬂow apparatus, followed by ﬂash photolysis of the blocking
CO ligand (see e.g. [31]). Upon CO dissociation, O2 binds to heme a3,
which initiates the reaction. Oxidation of the heme groups was
monitored time-resolved at a number of different wavelengths. Fig. 4
shows the absorbance changes at 445 nm and 605 nm at pH 7.4.
Earlier studies with wild-type R. sphaeroides CytcO have shown that
the absorbance changes reﬂect distinct transitions of the CytcO
catalytic cycle [31]. The initial instant increase in absorbance, most
clearly seen at 445 nm (Fig. 4b), is due to dissociation of the CO ligand.
Binding of O2 results in a decrease in absorbance with a time constant
of ~10 μs (at 1 mM O2). The subsequent transfer of an electron from
heme a to the catalytic site is seen at 605 nm (and also to some extent
at 445 nm) as an absorbance decrease with a time constant of ~40 μs.
This electron transfer is associated with breaking of the O―O bond
and formation of a state called “peroxy”, denoted PR. Next, a proton is
transferred from solution to the catalytic site, which results in
formation of a state called “ferryl”, denoted F. The PR→F reaction
displays a time constant of ~100 μs at pH 7.4 and it is also linked to
fractional electron transfer from CuA to heme a and proton-pumping.






























Fig. 5. Absorbance changes associated with the reaction of the four-electron reduced
CytcO with O2 at pH 10. At 580 nm, the increase in absorbance in the time range
~100 μs–500 μs is associated with the PR→F reaction. Experimental conditions: ~1 μM
































Fig. 4. Absorbance changes at pH 7.4 associated with the reaction of the four-electron
reduced CytcOwithO2measured at (a) 445 nmand (b) 605 nm. The absorbance increase
at t=0 is associated with dissociation of the CO ligand. The decrease in absorbance
following in time is associated with oxidation of the CytcO. Experimental conditions:
~1 μM reacting enzyme, 0.1 M HEPES-KOH pH 7.4, 0.1% DDM and 1 mM O2 at ~22 °C.
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pH 10 in Fig. 5). Finally, the last electron is transferred from the CuA-
heme a equilibrium to the catalytic site, linked to proton-uptake from
solution. The electron transfer is seen as a decrease in absorbance at
445 nm and 605 nmwith a time constant of ~1.2 ms at pH 7.4. As seen
in Fig. 4, all reaction steps upon oxidation of the four-electron reduced
CytcO were unaffected by the mutations at pH 7.4. This is also true for
the absorbance changes at 580 nm associatedwith the PR→F reaction
(not shown). Furthermore, because the Ser168 corresponds to an Ala
(Ala122) in the human mitochondrial CytcO, in addition to investi-
gating the Ser168Thr mutation, we tested the effect of a Ser168Ala
mutation in the R. sphaeroides CytcO. The behavior of this mutant
CytcOwas similar to that of the Ser168Thr structural variant (data not
shown).
Fig. 5 shows absorbance changes associated with the reaction
of the reduced CytcO with O2 at pH 10. At this pH there was no
signiﬁcant difference in the kinetics associated with the PR→F
reaction (Fig. 5a). However, the F→O transition with all four mutant
CytcOs was a factor of ~3 slower (~50 s−1) than with the wild-type
CytcO (~180 s−1) (Fig. 5b). Fig. 6 shows the pH dependence of the
PR→F and F→O rates. As seen in the ﬁgure, the difference in the
F→O rate appears only at high pH. The small difference seen in
the PR→F rates at pH 10 in Fig. 6a is not signiﬁcant (see, the increase
in absorbance, associated with the PR→F reaction, in Fig. 5a).
4. Discussion
In this work, we have investigated the effects of four mutations,
Asn25Ser, Ser168Thr, Ala384Ser and Val423Ile, on the function of
CytcO. The mutations were originally identiﬁed in tumor cells ofprostate cancer patients [13]. We introduced the equivalent amino-
acid residue substitutions into the CytcO of the bacterial model system
R. sphaeroides, which is structurally and functionally closely related
to the mammalian counterpart (Fig. 1). Although the substituted
amino-acid residues studied in this work are conserved, they are not
located within segments of subunit I in CytcO that have previously
been shown to be directly involved in the function of the enzyme.
The Val423 residue is positioned ~7 Å away from the heme a3 iron,
but on the “back side” of the catalytic site such that the distance to
CuB is 11 Å. The relative proximity to the heme a3 iron could result
in changes in ligand binding or the redox potential of this site,
but this was not observed experimentally at neutral pH. The absence
of any signiﬁcant effects on function is not unexpected given that the
substitution of a Val to an Ile is fairly conservative, where the latter is
larger by only one carbon atom.
The Ala384 residue, which was mutated to a Ser, is located in
between the two identiﬁed proton conducting pathways in SU I of
CytcO at a distance of 12 Å from Lys362 and 20 Å from Glu286,
i.e. most likely too far to directly inﬂuence the structural properties
of these pathways. The distance to the heme groups is ~20 Å.
The Ser168 residue is located at approximately the same depth
into the membrane as the heme propionates, but toward SUIII,
i.e. closer to heme a (~15 Å) than to heme a3. Furthermore, in the
mitochondrial CytcO the corresponding residue is located ~8 Å from
Asp51, a residue that has been implicated to be part of the proton-
gating machinery of that CytcO [32]. Results from an investigation of
effects of mutations at another amino-acid residue in this area, Gly171
[16], indicated that the substitution resulted in a proton leak through
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Fig. 6.ThepHdependenceof thePR→F and F→O reaction rates. ThePR→F rate constants
were determined from the data at 580 nm (see Fig. 5), while the F→O reaction rates
were determined from data at 445 nm. Experimental conditions: ~1 μM reacting enzyme,
0.1%DDMand1 mMO2 at ~22 °C, buffers as follows; 0.1 MMES (pH6.0–6.5), 0.1 MHEPES
(pH 7.0–7.5), 0.1 M Tris–HCl (pH 8.0–9.0), 0.1 M CHES (pH 9.5–10.0).
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protons that are pumped across the membrane are temporarily
stored. The effects of the Gly171Asp mutation were attributed to its
proximity to the Arg481 residue. Residue Ser168 is only three residues
away from the Gly171 at a distance of 5–6 Å, but it is further away
from the arginines compared to the Gly171. Interestingly, also the
results with the Ser168Thr mutant CytcO indicate that after the initial
proton release to the outside of the vesicles there is a slower, small
proton back leak (Fig. 3), not observed with the wild-type CytcO. This
putative leak is not as obvious as with the Gly171Asp mutants CytcO,
which is consistent with the difference in distances to the Arg481
residue. It is also interesting to note that a similar behavior was
observed with the Val423Ile and Ala384Ser mutant CytcOs, although
the leak is more pronounced with the Ser168Thr mutant CytcO.
Residue Asn25 is situated about 4–5 Å away from Asp132, which is
close to the entry point of the D proton-transfer pathway [18–20,33].
Even though removal of the carboxyl group at the position of the
Asp132 residue results in slowed proton-uptake rates [34], changes in
nearby residues do not change the proton-uptake rates dramatically
(unpublished data). Consequently, it is not surprising that essentially
no effects on the kinetics of proton transfer through the D-pathway
were observed with the Asn25Ser mutation, which would at most
result in a minor re-arrangement of the position of the carboxylate.
The steady-state turnover activities of the mutant CytcOs inves-
tigated in this study were at most a factor of two slower than that
of the wild-type CytcO (see Fig. 2). This activity is sensitive to e.g.
internal electron equilibria or pKa values of internal proton acceptors
or donors. A change in activity by a factor of two may be a
manifestation of minute changes in these parameters. Furthermore,
since the in vivo turnover activity of the respiratory chain is much
lower than the maximum activity of CytcO, a decrease in the CytcOactivity by a factor of two is unlikely to affect the overall electron/
proton ﬂux of the respiratory chain. Furthermore, we did not observe
any effects on the kinetics of speciﬁc electron- and proton-transfer
reactions during O2 reduction in the pH range 6–9 (see Fig. 4). The
only signiﬁcant difference in the reaction kinetics was a factor of ~3
decrease in the F → O rate with the mutant CytcOs at high pH
(~10). Notably, the same effect was observed with all four mutant
CytcOs. In view of the distinctly different location of the mutated
residues in different parts of the CytcO (see Fig. 1), the effects on
the F→O transition at pH 10 are likely to originate from structural
destabilization of the protein that occurs only at the highest
measured pH values. The rate constant of the F→O reaction is
determined by the electron equilibrium among the redox-active
cofactors of the CytcO as well as the proton-transfer rate through
the D-pathway. As the proton-transfer rate was not affected (see
above), the slowed F→O reaction at high pH is attributed to
changes in electron equilibrium among the redox sites, CuA, heme a
and the catalytic site.
As already mentioned above, the Asn25Ser, Ser168Thr, Ala384Ser
and Val423Ile mutations are all found at highly conserved sites.
However, the substitutions are relatively conservative andneutral, and
found in parts of the CytcO that have been shown not to be directly
involved in speciﬁc function. One property that is worth noting is the
small proton leak observed with the Ser168Thr, Ala384Ser and
Val423Ile mutant CytcOs, but not with the Asn25Ser mutant CytcO.
The three former mutations are all found within the membrane-
spanning part of the CytcO and 10–20 Å from the region involved in
proton gating. Consequently, if these mutations result in small
structural destabilization as discussed above, they may also affect
structural changes that are involved in the proton gating process. The
Asn25Ser mutation, on the other hand, is located at the protein
surface, ~30 Å away from the catalytic site.
In summary, the bacterial model system used in the present
studies allowed us to investigate in detail the effects of four subunit I
CytcO mutations identiﬁed in tumor cells of prostate cancer patients.
The data show that at neutral pH the turnover activity was reduced
by a factor of b2 and there were no effects on internal electron- or
proton-transfer. Three of the mutations resulted in minor proton
leaks, presumably due to structural destabilization of the gating
region of the pump. Furthermore, we observed a signiﬁcant slowing of
internal electron transfer to the catalytic site (F→O reaction) at pH
10, which is also presumably due to destabilization of the protein
structure. Even though these effects are relatively minor, the obser-
vation of proton leaks at neutral pH in three of the mutant CytcOs
indicates that the mutations result in a less robust proton pump. In
the presence of a transmembrane electrochemical potential such
changes may be more signiﬁcantly manifested and could result in a
less efﬁcient energy conversion of the entire respiratory chain.
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